Daniel Thomas - Select Medical Independent Director
SEM Stock | USD 30.15 0.70 2.38% |
Director
Mr. Daniel Thomas is Director of the Company. He joins the Board with over 30 years of healthcare industry experience. Mr. Thomas is currently an active board member for four established health organizations Concentra Group Holdings Parent, LLC, Healthcare Highways, Inc. and National Partners in Healthcare. From 2011 until his retirement in 2017, Mr. Thomas served as President, Chief Executive Officer and a board member of Provista, Inc. Prior to Provista, Mr. Thomas served as Chief Executive Officer and a board member of Viant, Inc. Before the formation of Viant, from 1993 through 2007, Mr. Thomas spent 14 years with Concentra, Inc. At Concentra, Mr. Thomas held the positions of President, Chief Executive Officer and Chief Operating Officer since 2019.
Age | 62 |
Tenure | 5 years |
Address | 4714 Gettysburg Road, Mechanicsburg, PA, United States, 17055 |
Phone | 717 972 1100 |
Web | https://www.selectmedical.com |
Select Medical Management Efficiency
The company has Return on Asset of 0.0452 % which means that on every $100 spent on assets, it made $0.0452 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2022 %, implying that it generated $0.2022 on every 100 dollars invested. Select Medical's management efficiency ratios could be used to measure how well Select Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Select Medical's Return On Capital Employed is very stable compared to the past year. As of the 29th of March 2024, Return On Equity is likely to grow to 0.20, while Return On Assets are likely to drop 0.02. At this time, Select Medical's Other Current Assets are very stable compared to the past year. As of the 29th of March 2024, Other Assets is likely to grow to about 202.7 M, while Non Current Assets Total are likely to drop about 4 B.Similar Executives
Found 12 records | DIRECTOR Age | ||
Michael Johns | AMN Healthcare Services | 78 | |
Mark Foletta | AMN Healthcare Services | 60 | |
Jeffrey Harris | AMN Healthcare Services | 63 | |
Julie Korinke | The Oncology Institute | N/A | |
Michael Gaynor | Novo Integrated Sciences | 49 | |
Rakesh MBA | The Oncology Institute | N/A | |
Mark Savich | AMN Healthcare Services | N/A | |
Andrew Stern | AMN Healthcare Services | 68 | |
Alec Pismiris | AMN Healthcare Services | 51 | |
Daphne Jones | AMN Healthcare Services | 64 | |
Paul Weaver | AMN Healthcare Services | 71 | |
Martha Marsh | AMN Healthcare Services | 72 |
Management Performance
Return On Equity | 0.2 | ||||
Return On Asset | 0.0452 |
Select Medical Holdings Leadership Team
Elected by the shareholders, the Select Medical's board of directors comprises two types of representatives: Select Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Select. The board's role is to monitor Select Medical's management team and ensure that shareholders' interests are well served. Select Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Select Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Saich, Executive Vice President Chief Human Resources Officer | ||
Bridget Sherick, Senior Services | ||
James Ely, Independent Director | ||
James Dalton, Independent Director | ||
Michael Malatesta, Executive CFO | ||
Russell Carson, Lead Independent Director | ||
Bryan Cressey, Independent Director | ||
Thomas Scully, Independent Director | ||
William Frist, Independent Director | ||
Martin Jackson, Chief Financial Officer, Executive Vice President | ||
Thomas Mullin, Executive Vice President - Hospital Operations | ||
Leopold Swergold, Independent Director | ||
Katherine Davisson, Independent Director | ||
Shelly Eckenroth, Marketing Communications | ||
David Chernow, President, Chief Executive Officer | ||
Christopher Weigl, Controller VP | ||
Robert Breighner, Vice President, Compliance and Audit Services and Corporate Compliance Officer | ||
Parvinderjit Khanuja, Independent Director | ||
Michael Tarvin, Executive Vice President General Counsel, Secretary | ||
John Duggan, Executive Counsel | ||
Rocco Ortenzio, Vice Chairman of the Board, Co-Founder | ||
Daniel Thomas, Independent Director | ||
Mary Lacey, Senior Officer | ||
Scott Romberger, Senior Vice President, Chief Accounting Officer, Controller | ||
Robert Ortenzio, Executive Chairman of the Board, Co-Founder | ||
Brian Rusignuolo, Executive Officer | ||
Joel Veit, VP Treasurer | ||
Marilyn Tavenner, Independent Director | ||
Harold Paz, Independent Director |
Select Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Select Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.2 | ||||
Return On Asset | 0.0452 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.07 % | ||||
Current Valuation | 8.6 B | ||||
Shares Outstanding | 128.36 M | ||||
Shares Owned By Insiders | 17.30 % | ||||
Shares Owned By Institutions | 77.93 % | ||||
Number Of Shares Shorted | 2.52 M | ||||
Price To Earning | 13.33 X |
Currently Active Assets on Macroaxis
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Select Medical Holdings information on this page should be used as a complementary analysis to other Select Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Select Stock analysis
When running Select Medical's price analysis, check to measure Select Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Select Medical is operating at the current time. Most of Select Medical's value examination focuses on studying past and present price action to predict the probability of Select Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Select Medical's price. Additionally, you may evaluate how the addition of Select Medical to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Select Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.668 | Dividend Share 0.5 | Earnings Share 1.91 | Revenue Per Share 54.133 | Quarterly Revenue Growth 0.049 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.